The strategic collaboration aims to enhance healthcare services in the region, providing comprehensive and cutting-edge diagnostic solutionsMedGenome has acquired a stake in GenX Diagnostics, a leading diagnostic lab chain in Odisha.Founded in 2017, GenX Diagnostics has established a robust regional presence in Odisha, with seven diagnostic centres and 60 collection centres across the state, including a flagship laboratory in Saheed Nagar, Bhubaneshwar, accredited by both NABL and NABH. The founding members of GenX Diagnostics are healthcare veterans, with Dr Biswajit Mohanty and Dr Bikash Agarwal being renowned lab medicine and radiology consultants, respectively, with more than 2-3 decades of clinical experience.Dr Vedam Ramprasad, CEO, MedGenome, said, "With the acquisition of a stake in GenX Diagnostics, MedGenome will expand its market presence and product portfolio of over 1300 tests to cater to a wider population base more effectively. GenX Diagnostics sits perfectly with our vision and mission to leverage genomics to address the unmet healthcare need in the country. Their mission to provide quality, reliable, and innovative diagnostic solutions aligns with our focus on improving access to broader omics solutions. This acquisition further aims to expand our network in Tier 2 and Tier 3 cities in India by driving deeper penetration, new market development, and bringing new tests to the market. With a focus on positioning Indian genomics globally, we develop solutions that cater to diverse markets worldwide.”"The strategic collaboration aims to enhance healthcare services in the region, providing comprehensive and cutting-edge diagnostic solutions. We are committed to bringing sophisticated and advanced healthcare solutions to the people of Odisha. By combining our extensive product portfolio with MedGenome’s omics solutions, we will empower clinicians and consumers in Eastern India with the best diagnostic tools available,” said Dr Mohanty.